Healthcare providers play a pivotal role in ensuring medicine safety, yet knowledge gaps persist in identifying and responding to substandard and falsified (SF) medical products. This moderated session will present key findings from research studies, program evaluations, and provider surveys that shed light on the current state of awareness, knowledge, and practices among healthcare professionals. Panelists will discuss how evidence from diverse contexts can inform education, policy, and clinical practice to better equip providers in preventing and reporting SF medicines. The session will also allow participants to engage directly with presenters based on their areas of interest.